213 related articles for article (PubMed ID: 1301172)
1. Identification of a highly polymorphic marker within intron 7 of the ALAS2 gene and suggestion of at least two loci for X-linked sideroblastic anemia.
Cox TC; Kozman HM; Raskind WH; May BK; Mulley JC
Hum Mol Genet; 1992 Nov; 1(8):639-41. PubMed ID: 1301172
[TBL] [Abstract][Full Text] [Related]
2. Assignment of human erythroid delta-aminolevulinate synthase (ALAS2) to a distal subregion of band Xp11.21 by PCR analysis of somatic cell hybrids containing X; autosome translocations.
Cotter PD; Willard HF; Gorski JL; Bishop DF
Genomics; 1992 May; 13(1):211-2. PubMed ID: 1577484
[TBL] [Abstract][Full Text] [Related]
3. Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts.
Cotter PD; May A; Fitzsimons EJ; Houston T; Woodcock BE; al-Sabah AI; Wong L; Bishop DF
J Clin Invest; 1995 Oct; 96(4):2090-6. PubMed ID: 7560104
[TBL] [Abstract][Full Text] [Related]
4. Pyridoxine-refractory congenital sideroblastic anaemia with evidence for autosomal inheritance: exclusion of linkage to ALAS2 at Xp11.21 by polymorphism analysis.
Jardine PE; Cotter PD; Johnson SA; Fitzsimons EJ; Tyfield L; Lunt PW; Bishop DF
J Med Genet; 1994 Mar; 31(3):213-8. PubMed ID: 7912287
[TBL] [Abstract][Full Text] [Related]
5. X-linked pyridoxine-responsive sideroblastic anemia due to a Thr388-to-Ser substitution in erythroid 5-aminolevulinate synthase.
Cox TC; Bottomley SS; Wiley JS; Bawden MJ; Matthews CS; May BK
N Engl J Med; 1994 Mar; 330(10):675-9. PubMed ID: 8107717
[TBL] [Abstract][Full Text] [Related]
6. A novel mutation in exon 5 of the ALAS2 gene results in X-linked sideroblastic anemia.
Hurford MT; Marshall-Taylor C; Vicki SL; Zhou JZ; Silverman LM; Rezuke WN; Altman A; Tsongalis GJ
Clin Chim Acta; 2002 Jul; 321(1-2):49-53. PubMed ID: 12031592
[TBL] [Abstract][Full Text] [Related]
7. X-linked sideroblastic anemia: identification of the mutation in the erythroid-specific delta-aminolevulinate synthase gene (ALAS2) in the original family described by Cooley.
Cotter PD; Rucknagel DL; Bishop DF
Blood; 1994 Dec; 84(11):3915-24. PubMed ID: 7949148
[TBL] [Abstract][Full Text] [Related]
8. Molecular defects of erythroid 5-aminolevulinate synthase in X-linked sideroblastic anemia.
Bottomley SS; May BK; Cox TC; Cotter PD; Bishop DF
J Bioenerg Biomembr; 1995 Apr; 27(2):161-8. PubMed ID: 7592563
[TBL] [Abstract][Full Text] [Related]
9. Linkage analysis of a large pedigree with hereditary sideroblastic anaemia.
Noble JS; Taylor GR; Losowsky MS; Hall R; Turner G; Mueller RF; Stewart AD
J Med Genet; 1995 May; 32(5):389-92. PubMed ID: 7616548
[TBL] [Abstract][Full Text] [Related]
10. Familial-skewed X-chromosome inactivation as a predisposing factor for late-onset X-linked sideroblastic anemia in carrier females.
Cazzola M; May A; Bergamaschi G; Cerani P; Rosti V; Bishop DF
Blood; 2000 Dec; 96(13):4363-5. PubMed ID: 11110715
[TBL] [Abstract][Full Text] [Related]
11. [A novel mutation of the ALAS2 gene in a family with X-linked sideroblastic anemia].
Zhu P; Bu D
Zhonghua Xue Ye Xue Za Zhi; 2000 Sep; 21(9):478-81. PubMed ID: 11877024
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel erythroid-specific enhancer for the ALAS2 gene and its loss-of-function mutation which is associated with congenital sideroblastic anemia.
Kaneko K; Furuyama K; Fujiwara T; Kobayashi R; Ishida H; Harigae H; Shibahara S
Haematologica; 2014 Feb; 99(2):252-61. PubMed ID: 23935018
[TBL] [Abstract][Full Text] [Related]
13. X-linked sideroblastic anemia due to ALAS2 intron 1 enhancer element GATA-binding site mutations.
Campagna DR; de Bie CI; Schmitz-Abe K; Sweeney M; Sendamarai AK; Schmidt PJ; Heeney MM; Yntema HG; Kannengiesser C; Grandchamp B; Niemeyer CM; Knoers NV; Swart S; Marron G; van Wijk R; Raymakers RA; May A; Markianos K; Bottomley SS; Swinkels DW; Fleming MD
Am J Hematol; 2014 Mar; 89(3):315-9. PubMed ID: 24166784
[TBL] [Abstract][Full Text] [Related]
14. A promoter mutation in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causes X-linked sideroblastic anemia.
Bekri S; May A; Cotter PD; Al-Sabah AI; Guo X; Masters GS; Bishop DF
Blood; 2003 Jul; 102(2):698-704. PubMed ID: 12663458
[TBL] [Abstract][Full Text] [Related]
15. [Progress of study on sideroblastic anemia and its possible gene therapy--review].
Wang YQ; Zhu P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):524-8. PubMed ID: 15972158
[TBL] [Abstract][Full Text] [Related]
16. A novel mutation of the erythroid-specific gamma-Aminolevulinate synthase gene in a patient with non-inherited pyridoxine-responsive sideroblastic anemia.
Harigae H; Furuyama K; Kudo K; Hayashi N; Yamamoto M; Sassa S; Sasaki T
Am J Hematol; 1999 Oct; 62(2):112-4. PubMed ID: 10577279
[TBL] [Abstract][Full Text] [Related]
17. Four new mutations in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causing X-linked sideroblastic anemia: increased pyridoxine responsiveness after removal of iron overload by phlebotomy and coinheritance of hereditary hemochromatosis.
Cotter PD; May A; Li L; Al-Sabah AI; Fitzsimons EJ; Cazzola M; Bishop DF
Blood; 1999 Mar; 93(5):1757-69. PubMed ID: 10029606
[TBL] [Abstract][Full Text] [Related]
18. New mutation in erythroid-specific delta-aminolevulinate synthase as the cause of X-linked sideroblastic anemia responsive to pyridoxine.
Kucerova J; Horvathova M; Mojzikova R; Belohlavkova P; Cermak J; Divoky V
Acta Haematol; 2011; 125(4):193-7. PubMed ID: 21252495
[TBL] [Abstract][Full Text] [Related]
19. [Construction of recombinant vector expressing ALAS2 gene in X-linked sideroblastic anemia].
Wang YQ; Zhu P; Shi YJ; Gu JY; Bu DF; Liu H; Zhang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Oct; 12(5):687-93. PubMed ID: 15498136
[TBL] [Abstract][Full Text] [Related]
20. A Novel
Lee JS; Gu J; Yoo HJ; Koh Y; Kim HK
Ann Clin Lab Sci; 2017 May; 47(3):319-322. PubMed ID: 28667034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
